» Articles » PMID: 35666374

Clinical Significance of Hemodialysis Quality of Care Indicators in Very Elderly Patients With end Stage Kidney Disease

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2022 Jun 6
PMID 35666374
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Improvement in life expectancy has increased the number of very elderly patients undergoing hemodialysis. However, it is not clear which quality measures for hemodialysis should be employed in this population. Therefore, in this paper we investigated the association between major adverse cardiovascular and cerebrovascular events (MACCE) indicators of hemodialysis quality in very elderly patients. PATIENTS AND METHODS: Data regarding a total of 29,692 patients undergoing maintenance hemodialysis (median age 61 years, 41.5% females) who participated in a national hemodialysis quality assessment program were analyzed. They were divided into < 80 years and ≥ 80 years age groups. The primary and secondary outcomes were MACCE and all-cause mortality, respectively. The association between the outcomes and some of the most widely used standard hemodialysis quality-of-care indicators, including spKt/V, hemoglobin, serum calcium, serum phosphate, and albumin levels, was evaluated. To explore the association between Cox proportional hazard models were constructed. Model 1 was adjusted for age and sex. Model 2 included additional demographic characteristics, such as Charlson Comorbidity Index (excluding diabetes), diabetes, cause of ESKD, dialysis vintage, BMI, and pre-dialysis systolic blood pressure. Model 3 was further adjusted for the main medications. To evaluate the relationship between MACCE risk and quality assessment indicators as a continuous variable, cubic spline analyses were conducted.

Results: During a median follow-up of 3.7 years, MACCE occurred at a higher rate in the ≥ 80-years group than in the < 80-years group (282.0 vs. 110.1 events/1000 person-years). Multivariate Cox regression analysis revealed that spKt/V, serum calcium and phosphate, and hemoglobin levels were associated with MACCE and all-cause mortality risk in patients aged < 80 years. However, these indicators showed no significant relationship with MACCE and all-cause mortality in patients aged ≥ 80 years. Low serum albumin levels were significantly associated with increased MACCE and all-cause mortality risks, regardless of age.

Conclusion: In conclusion, hemodialysis quality-of-care indicators including spKt/V, serum calcium and phosphate levels, and hemoglobin were not related to MACCE or all-cause mortality in very elderly hemodialysis patients. However, lower serum albumin levels were associated with poor outcomes, regardless of patient age. Assuring nutritional status rather than improving hemodialysis management adequacy may be more beneficial for improving outcomes in very elderly hemodialysis patients. Further prospective evaluations are needed to confirm these findings.

Citing Articles

Systemic Lupus Erythematosus in Hemodialysis: Survival Comparison and Mortality-Related Factors.

Lee H, Kang S Medicina (Kaunas). 2025; 61(1.

PMID: 39859137 PMC: 11767054. DOI: 10.3390/medicina61010155.


Risk factors for cardiovascular and cerebrovascular events in patients with uremia and hypertension during maintenance hemodialysis.

Zhang X, Zhang W, Wang F, Chu Y Am J Transl Res. 2024; 16(4):1228-1236.

PMID: 38715830 PMC: 11070352. DOI: 10.62347/UAZN4638.


Effect of spironolactone on survival in patients undergoing maintenance hemodialysis.

Kang S, Kim B, Son E, Kim G, Do J PLoS One. 2024; 19(3):e0301458.

PMID: 38551953 PMC: 10980200. DOI: 10.1371/journal.pone.0301458.


Risk Factors of Cardiovascular and Cerebrovascular Events in Patients With Uraemia Complicated With Hypertension During Maintenance Haemodialysis Treatment.

Nizami A, Mustafa W, Qadir M, Shahzad M, Iqbal H, Ali A Cureus. 2024; 16(2):e53411.

PMID: 38435216 PMC: 10908417. DOI: 10.7759/cureus.53411.


Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis.

Kang S, Kim B, Son E, Kim G, Do J Biomedicines. 2023; 11(10).

PMID: 37893212 PMC: 10603865. DOI: 10.3390/biomedicines11102838.


References
1.
Brown E, Johansson L . Epidemiology and management of end-stage renal disease in the elderly. Nat Rev Nephrol. 2011; 7(10):591-8. DOI: 10.1038/nrneph.2011.113. View

2.
Kurella Tamura M, Covinsky K, Chertow G, Yaffe K, Landefeld C, McCulloch C . Functional status of elderly adults before and after initiation of dialysis. N Engl J Med. 2009; 361(16):1539-47. PMC: 2789552. DOI: 10.1056/NEJMoa0904655. View

3.
Han S, Park J, Kang S, Kim K, Ryu D, Kim H . Dialysis Modality and Mortality in the Elderly: A Meta-Analysis. Clin J Am Soc Nephrol. 2015; 10(6):983-93. PMC: 4455206. DOI: 10.2215/CJN.05160514. View

4.
Jin D, Yun S, Lee S, Han S, Kim W, Park J . Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients. Kidney Res Clin Pract. 2016; 35(4):204-211. PMC: 5142391. DOI: 10.1016/j.krcp.2016.09.006. View

5.
Joly D, Anglicheau D, Alberti C, Nguyen A, Touam M, Grunfeld J . Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003; 14(4):1012-21. DOI: 10.1097/01.asn.0000054493.04151.80. View